Bioactivity and Regenerative Potential of Calcium Silicate-Based Endodontic Sealers on Human Periodontal Ligament Stem Cells: A Systematic Review of In Vitro Cellular Mechanisms.
5 affiliations
- 1Dentistry, Majmaah University, Riyadh, SAU.
- 2Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, SAU.
- 3Dentistry, Vision College, Riyadh, SAU.
- 4General Dentistry, Security Forces Hospital Dammam, General Administration of Medical Services, Ministry of Interior, Dammam, SAU.
- 5Endodontics, King Fahd Hospital, Madinah Health Cluster, Madinah, SAU.
Abstract
Calcium silicate-based endodontic sealers are bioactive obturation materials that may support periapical regeneration, yet in vitro evidence remains fragmented and methodologically heterogeneous. This review evaluated whether these sealers show consistent cellular bioactivity in human periodontal ligament stem cells (hPDLSCs) and which outcomes and formulations show the most favourable regenerative potential. The review followed a predefined methodology informed by the Cochrane Handbook and was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. PubMed/MEDLINE, Scopus, Web of Science, the Cochrane Central Register of Controlled Trials, and Google Scholar were searched using Population, Intervention, Comparison, Outcomes, and Study design-based strategies. Risk of bias was assessed with the National Toxicology Program - Office of Health Assessment and Translation (NTP-OHAT) tool. Because materials, extract dilutions, exposure periods, assay protocols, and effect measures varied substantially, a structured narrative synthesis was undertaken instead of meta-analysis. Of 891 records, 15 studies met the eligibility criteria. Most used primary hPDLSCs characterised by mesenchymal stem-cell markers and compared calcium silicate-based sealers, including TotalFill BC Sealer (FKG Dentaire Sàrl, Le Crêt-du-Locle, Switzerland)/EndoSequence BC Sealer (Brasseler U.S.A. Dental, LLC, Savannah, Georgia, USA), BioRoot RCS (Septodont, Saint-Maur-des-Fossés, France), CeraSeal (Meta Biomed Co., Ltd., Cheongju, Republic of Korea), Bio-C Sealer (Angelus, Londrina, Brazil), Well-Root ST (VERICOM Co., Ltd., Chuncheon, Republic of Korea), and NeoSEALER Flo (Avalon Biomed, Houston, Texas, USA), with epoxy resin-based sealers, predominantly AH Plus (Dentsply DeTrey GmbH, Konstanz, Germany). Overall risk of bias was low, although blinding of outcome assessment was often unclear. Across 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and CCK-8 assays, calcium silicate-based sealers generally maintained or increased cellular metabolic activity, whereas AH Plus showed lower activity; NeoSEALER Flo and EndoSeal MTA (Maruchi, Wonju, Republic of Korea) showed less favourable or intermediate responses. Twelve scratch-wound studies reported migration comparable with or greater than controls; eleven Alizarin Red S studies reported increased mineral deposition, most pronounced for TotalFill BC Sealer/EndoSequence BC Sealer and BioRoot RCS; and eleven reverse transcription quantitative polymerase chain reaction (RT-qPCR) studies reported upregulation of osteogenic and cementogenic markers, including ALP, RUNX2, CEMP1, and CAP. Six studies assessed inflammatory or immunomodulatory responses; most reported lower pro-inflammatory cytokine expression, particularly IL-6 and IL-8, with calcium silicate-based sealers than with AH Plus, although responses varied by formulation and exposure time. Within the limits of two-dimensional models and heterogeneous protocols, contemporary calcium silicate-based root canal sealers appear more cytocompatible and biologically active toward hPDLSCs than conventional epoxy resin sealers, supporting favourable cellular metabolic activity, migration, mineralisation, and osteogenic and cementogenic differentiation. This review assessed whether calcium silicate-based sealers are cytocompatible and promote regenerative bioactivity in hPDLSCs.
Related
- Regenerative Endodontic Procedure in Mandibular First Molar: A Clinical Case Report
- Strategic Orthograde Biodentine Obturation and Regenerative Surgical Management of a Persistent Radicular Cyst Refractory to Nonsurgical Endodontic Therapy: A One-Year Follow-Up Case Report.
- Comparative evaluation of clinical and radiographic outcomes of three different scaffolds in regenerative endodontic treatment – A randomized clinical trial
- Clinical efficacy and prognostic factors of regenerative endodontic procedure for immature permanent teeth with periapical periodontitis.
- Chitosan‐Based Hydrogels for Periodontal Therapy: From Drug‐Polymer Chemistry to Smart Multifunctional and Regenerative Systems
BibTeX
@article{yaseen2026bioactivity,
title = {{Bioactivity and Regenerative Potential of Calcium Silicate-Based Endodontic Sealers on Human Periodontal Ligament Stem Cells: A Systematic Review of In Vitro Cellular Mechanisms.}},
author = {Fahad I Yaseen and Abdulaziz M Alribi and Yasser K AlGhadyan and Nawaf A Alshehri and Thamer M Alanazi and Abdullah S Aldhafeeri and Marwan S Alyousef and Shaykha S Elkherayef and Abdulrahman A Albarqi and Abdulrahman M Alqahtani and Ali M Falatah},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116629},
url = {https://europepmc.org/article/MED/42910053},
note = {CC BY},
}
RIS
TY - JOUR
TI - Bioactivity and Regenerative Potential of Calcium Silicate-Based Endodontic Sealers on Human Periodontal Ligament Stem Cells: A Systematic Review of In Vitro Cellular Mechanisms.
AU - Fahad I Yaseen
AU - Abdulaziz M Alribi
AU - Yasser K AlGhadyan
AU - Nawaf A Alshehri
AU - Thamer M Alanazi
AU - Abdullah S Aldhafeeri
AU - Marwan S Alyousef
AU - Shaykha S Elkherayef
AU - Abdulrahman A Albarqi
AU - Abdulrahman M Alqahtani
AU - Ali M Falatah
PY - 2026
DA - 2026/09/21
JO - Cureus
DO - 10.7759/cureus.116629
UR - https://europepmc.org/article/MED/42910053
AB - Calcium silicate-based endodontic sealers are bioactive obturation materials that may support periapical regeneration, yet in vitro evidence remains fragmented and methodologically heterogeneous. This review evaluated whether these sealers show consistent cellular bioactivity in human periodontal ligament stem cells (hPDLSCs) and which outcomes and formulations show the most favourable regenerative potential. The review followed a predefined methodology informed by the Cochrane Handbook and was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. PubMed/MEDLINE, Scopus, Web of Science, the Cochrane Central Register of Controlled Trials, and Google Scholar were searched using Population, Intervention, Comparison, Outcomes, and Study design-based strategies. Risk of bias was assessed with the National Toxicology Program - Office of Health Assessment and Translation (NTP-OHAT) tool. Because materials, extract dilutions, exposure periods, assay protocols, and effect measures varied substantially, a structured narrative synthesis was undertaken instead of meta-analysis. Of 891 records, 15 studies met the eligibility criteria. Most used primary hPDLSCs characterised by mesenchymal stem-cell markers and compared calcium silicate-based sealers, including TotalFill BC Sealer (FKG Dentaire Sàrl, Le Crêt-du-Locle, Switzerland)/EndoSequence BC Sealer (Brasseler U.S.A. Dental, LLC, Savannah, Georgia, USA), BioRoot RCS (Septodont, Saint-Maur-des-Fossés, France), CeraSeal (Meta Biomed Co., Ltd., Cheongju, Republic of Korea), Bio-C Sealer (Angelus, Londrina, Brazil), Well-Root ST (VERICOM Co., Ltd., Chuncheon, Republic of Korea), and NeoSEALER Flo (Avalon Biomed, Houston, Texas, USA), with epoxy resin-based sealers, predominantly AH Plus (Dentsply DeTrey GmbH, Konstanz, Germany). Overall risk of bias was low, although blinding of outcome assessment was often unclear. Across 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and CCK-8 assays, calcium silicate-based sealers generally maintained or increased cellular metabolic activity, whereas AH Plus showed lower activity; NeoSEALER Flo and EndoSeal MTA (Maruchi, Wonju, Republic of Korea) showed less favourable or intermediate responses. Twelve scratch-wound studies reported migration comparable with or greater than controls; eleven Alizarin Red S studies reported increased mineral deposition, most pronounced for TotalFill BC Sealer/EndoSequence BC Sealer and BioRoot RCS; and eleven reverse transcription quantitative polymerase chain reaction (RT-qPCR) studies reported upregulation of osteogenic and cementogenic markers, including ALP, RUNX2, CEMP1, and CAP. Six studies assessed inflammatory or immunomodulatory responses; most reported lower pro-inflammatory cytokine expression, particularly IL-6 and IL-8, with calcium silicate-based sealers than with AH Plus, although responses varied by formulation and exposure time. Within the limits of two-dimensional models and heterogeneous protocols, contemporary calcium silicate-based root canal sealers appear more cytocompatible and biologically active toward hPDLSCs than conventional epoxy resin sealers, supporting favourable cellular metabolic activity, migration, mineralisation, and osteogenic and cementogenic differentiation. This review assessed whether calcium silicate-based sealers are cytocompatible and promote regenerative bioactivity in hPDLSCs.
SN - 2168-8184
ER -